Fact checked by Jennifer Klump Key Takeaways Susvimo is an FDA-approved eye implant for diabetic macular edema that can be refilled every six months instead of requiring monthly injections.Diabetic ...

What Is Eylea HD, and Why Does It Matter? Eylea HD (aflibercept) is an injectable medicine used to treat certain eye conditions that can lead to vision loss. It works by blocking a protein called VEGF ...

Luminopia, Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, today announced that CareFirst BlueCross BlueShield, a large health plan servicing patients ...

A novel treatment for Leber's Hereditary Optic Neuropathy (LHON), a rare genetic disease that can lead to sudden loss of vision, has been approved for NHS patients following a successful clinical ...

Artificial intelligence is radically changing how healthcare providers tackle vision loss, with tools that can be used from diagnosis to treatment and even follow-up care. One such example is Visilant ...

FDA authorization under an IND permits first-in-human phase I/II testing of SVT-001 in familial drusen, focusing on safety ...

Glaucoma causes irreversible vision loss affecting 80 million people; World Glaucoma Week 2026 urges early eye exams, awareness, and treatment to prevent blindness.

Sudden blurry vision in one eye can sometimes signal serious eye emergencies such as retinal detachment, eye stroke, glaucoma, or optic neuritis. Ophthalmologist Dr Neeraj Sanduja explains warning ...